Invention Grant
- Patent Title: Thiazolidin-4-one-derivatives
- Patent Title (中): 噻唑烷-4-酮衍生物
-
Application No.: US13951954Application Date: 2013-07-26
-
Publication No.: US09000018B2Publication Date: 2015-04-07
- Inventor: Christoph Binkert , Martin Bolli , Boris Mathys , Claus Mueller , Michael Scherz , Oliver Nayler
- Applicant: Actelion Pharmaceuticals Ltd.
- Applicant Address: CH Allschwil
- Assignee: Actelion Pharmaceuticals, Ltd
- Current Assignee: Actelion Pharmaceuticals, Ltd
- Current Assignee Address: CH Allschwil
- Agency: Hoxie & Associates, LLC
- Priority: WOPCT/EP2003/013072 20031121
- Main IPC: A01N43/78
- IPC: A01N43/78 ; A61K31/425 ; C07D277/00 ; C07D277/54 ; A61K31/426 ; C07D277/20 ; C07D277/42 ; C07D417/06
Abstract:
The invention relates to pharmaceutical compositions containing at least one thiazolidin-4-one derivative to prevent or treat disorders associated with an activated immune system. Furthermore, the invention relates to novel thiazolidin-4-one derivatives notably for use as pharmaceutically active compounds. Said compounds particularly act also as immunosuppressive agents.
Public/Granted literature
- US20130310432A1 NOVEL THIAZOLIDIN-4-ONE-DERIVATIVES Public/Granted day:2013-11-21
Information query
IPC分类:
